Cargando…
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
The first local spread of COVID-19 in Israel was detected in March 2020. Due to the diversity in clinical presentations of COVID-19, diagnosis by RT-PCR alone might miss patients with mild or no symptoms. Serology testing may better evaluate the actual magnitude of the spread of infection in the pop...
Autores principales: | Reicher, Shay, Ratzon, Ronit, Ben-Sahar, Shay, Hermoni-Alon, Sharon, Mossinson, David, Shenhar, Yotam, Friger, Michael, Lustig, Yaniv, Alroy-Preis, Sharon, Anis, Emilia, Sadetzki, Siegal, Kaliner, Ehud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059683/ https://www.ncbi.nlm.nih.gov/pubmed/33884542 http://dx.doi.org/10.1007/s10654-021-00749-1 |
Ejemplares similares
-
Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel
por: Anis, Emilia, et al.
Publicado: (2022) -
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021) -
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
por: Lustig, Yaniv, et al.
Publicado: (2021) -
Civil-military cooperation to contain COVID-19 epidemic in Israel- Lesson learned: Zohar Mor
por: Mor, Z, et al.
Publicado: (2022) -
Seroprevalence of Rhodococcus equi in horses in Israel
por: Tirosh-Levy, Sharon, et al.
Publicado: (2017)